Business Segments · Business acquisitions

Sleep And Breathing Health — Business acquisitions

ResMed Sleep And Breathing Health — Business acquisitions decreased by 25.2% to $18.94M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 25.2%, from $25.33M to $18.94M.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ3 2024
Last reportedQ1 2026

How to read this metric

High activity suggests an aggressive growth strategy, while low activity suggests a focus on organic growth or integration.

Detailed definition

Tracks the capital deployed for the purchase of new businesses or product lines specifically integrated into the Sleep a...

Peer comparison

Commonly reported in cash flow statements or segment disclosures for companies pursuing M&A.

Metric ID: rmd_segment_sleep_and_breathing_health_business_acquisitions

Historical Data

5 periods
 Q3 '24Q4 '24Q1 '25Q2 '25Q1 '26
Value$25.33M$25.33M$25.33M$25.33M$18.94M
QoQ Change+0.0%+0.0%+0.0%-25.2%
YoY Change-25.2%
Range$18.94M$25.33M
CAGR-25.2%
Avg YoY Growth-25.2%
Median YoY Growth-25.2%

Frequently Asked Questions

What is ResMed's sleep and breathing health — business acquisitions?
ResMed (RMD) reported sleep and breathing health — business acquisitions of $18.94M in Q1 2026.
How has ResMed's sleep and breathing health — business acquisitions changed year-over-year?
ResMed's sleep and breathing health — business acquisitions decreased by 25.2% year-over-year, from $25.33M to $18.94M.
What does sleep and breathing health — business acquisitions mean?
The total capital spent on acquiring new businesses to grow the Sleep and Breathing Health segment.